The Guardian | Women’s health
‘Dream come true’: study suggests drug could extend women’s fertility by five years
Co-lead says rapamycin can be repurposed to slow ovaries from ageing and is safe for younger women
ousin Suh, a professor of reproductive sciences and professor of genetics and development at Columbia University and Zev Williams, associate professor of women’s health and the chief of the division of reproductive endocrinology and infertility at Columbia University Irving Medical Center, co-led on the study.
Suh said early results suggested it was realistic to hope the drug could decrease ovary ageing by 20% without women experiencing any of the 44 side-effects rapamycin can have, which range from mild nausea and headaches to high blood pressure and infections.
